A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer

BACKGROUND: TP53 gene mutation is one of the most common mutations in human bladder cancer (BC) and has been implicated in the progression and prognosis of BC. METHODS: RNA sequencing data and TP53 mutation data in different populations and platforms were downloaded from The Cancer Genome Atlas (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiangkun, Lv, Daojun, Cai, Chao, Zhao, Zhijian, Wang, Ming, Chen, Wenzhe, Liu, Yongda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774015/
https://www.ncbi.nlm.nih.gov/pubmed/33391264
http://dx.doi.org/10.3389/fimmu.2020.590618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774015/
https://www.ncbi.nlm.nih.gov/pubmed/33391264
http://dx.doi.org/10.3389/fimmu.2020.590618

Ejemplares similares